focus -WSS

focus

author：Wikipedia 2025-10-02 16:18:50 - browse：1

Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity drug that specifically targets fat mass, as the race among pharmaceutical companies to offer weight loss medications intensifies.

The deal indicates Lilly is aiming to diversify its growing portfolio of weight loss therapies, as Versanis’ drug employs an entirely different mechanism than the existing obesity drugs that Lilly is studying. The pharma giant didn’t say how much it would pay Versanis upfront, but said that if the drug meets certain milestones, the total payment could reach $1.9 billion.

Lilly, along with other pharma companies like Novo Nordisk, has been developing products in the class of GLP-1 drugs, which mimic the glucagon-like peptide 1 hormone that helps people feel full. These drugs – including Novo’s Ozempic and Wegovy, and Lilly’s Mounjaro – have exploded in popularity because they lead to significant weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： 3 hurdles to bringing medical devices to the U.S. market

WSS

TikTok cracks down on users posting about weight loss drugs

Cloning humans is technically possible. It's curious no one has tried

Colonoscopy at 40? Study finds a possible benefit

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

CDC concerned about possible undetected monkeypox spread in U.K.

Couple fighting to bring baby home from Mexico are finally reunited

focus

focus

Wikipedia

Drug repurposing or repositioning? The language matters

3 hurdles to bringing medical devices to the U.S. market

State Dept. review finds Biden bears some blame for Afghanistan failures

What would happen to your eyes if you looked at the solar eclipse?

Anesthesiologist group: stop taking Ozempic before surgery

Why we need to separate burnout from moral injury in health care

Peter Hotez and the public health issue of online harassment

Couple fighting to bring baby home from Mexico are finally reunited

Drug repurposing or repositioning? The language matters

WATCH: Why do fingernails fall off when they're damaged?

entertainment

TikTok cracks down on users posting about weight loss drugs

Why drug prescriptions should include diagnoses

Weight bias in eating disorder treatment complicated by new weight loss drugs

Celebrate National Dole Whip Day for 3 days this week at Disney

Disclosing genetic information: not as worrisome as once feared

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

focus

hotspot

hotspot

leisure time